Case File
efta-efta00682250DOJ Data Set 9OtherFrom: "Barrett, Paul S"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00682250
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S"
To: Jeffrey Epstein <[email protected]>
CC: "Giuffrida, David J"
Subject: RE: Oil and SGD
Date: Tue, 08 Mar 2011 21:30:07 +0000
We sold 2.5MM of the Ford 7% 2015 at 108.50
Bought 2.5MM of the American Axel 7.875% 2017 at 104.625
Thanks
Paul
From: Jeffrey Epstein [milt°
Sent: Tuesday, March 08, 2011 3:10 PM
To: Barrett, Paul S
Subject: Re: Oil and SGD
ok
On Tue, Mar 8, 2011 at 11:58 AM, Barrett, Paul S<
> wrote:
One last thing:
We have 5.2MM of the Ford 7% 2015 which is currently yielding 4.75%. I think we should switch half of the position into
American Axel 7.875% 2017. You pick up 200bps over F. AXL supplies parts to the major motor companies and this will
diversify our exposure away from F given how much the F bonds have rallied. We also own $5MM of the Ford 2011's.
Let me know
Paul
From: Jeffrey Epstein [mailto:
Sent: Tuesday, March 08, 2011 12:04 PM
To: Barrett, Paul S
Subject: Re: Oil and SGD
ok
On Tue, Mar 8, 2011 at 8:53 AM, Barrett, Paul S
wrote:
Hi Jeffrey
What are your thoughts on oil? We still own 50,000 of the 100 calls expiring in June and 50,000 of the 92/100 call spread.
My sense is we sit tight given the risk of higher oil prices on the rest of our positions.
On a separate note I think we should add another 5MM to SGD this week. I would like to get in around 1.2700. Can I take
an order?
Thanks
EFTA00682250
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to
and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to
and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00682251
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and corn leteness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at
EFTA00682252
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.